CIK: 1706847 - Address: C/O Black Diamond Therapeutics, Inc., One Main Street, 14Th Floor, Cambridge, MA 02142
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/10/23 16:11
8/8/23
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDM.d230.3859060107116D
8/10/23 16:11
8/8/23
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.d-1202.000-60-34116D
10/20/22 16:05
10/18/22
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDM.d60.390001515116D
10/20/22 16:05
10/18/22
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.d-17511.700-15-11116D
9/22/22 16:40
9/20/22
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDM.d80.390002021116D
9/22/22 16:40
9/20/22
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.d-27013.500-20-15116D
8/18/22 16:06
8/16/22
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDM.d310.3900080222116D
8/18/22 16:06
8/16/22
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.d-1,01112.640-80-41116D
2/8/22 16:05
2/7/22
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDM.d60.390001515116D
11/10/21 16:05
11/9/21
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDM.d160.390004066101D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact